Used in pharmaceutical research as a potent and selective inhibitor of the enzyme phosphodiesterase 10A (PDE10A). This enzyme is primarily found in the brain, particularly in the striatum, and plays a key role in regulating signaling pathways involved in mood, cognition, and motor control. Due to its action on PDE10A, this compound is investigated for potential therapeutic applications in neurological and psychiatric disorders such as schizophrenia, Huntington’s disease, and other conditions involving dysregulation of dopaminergic and glutamatergic signaling. Its high selectivity and ability to cross the blood-brain barrier make it a valuable tool compound in preclinical studies aimed at understanding PDE10A-related pathways and evaluating target engagement in vivo.